<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The current guidelines of the German Society for <z:e sem="disease" ids="C0012242" disease_type="Disease or Syndrome" abbrv="">Digestive Diseases</z:e> (DGVS) endoscopy recommends for patients representing with reflux symptoms </plain></SENT>
<SENT sid="1" pm="."><plain>In daily routine as well as in Guidelines from other countries and international guidelines, however, a symptom-based strategy for the management of patients with reflux disease is favoured </plain></SENT>
<SENT sid="2" pm="."><plain>Since either strategies is dependent on specific clinical findings, neither can be recommended </plain></SENT>
<SENT sid="3" pm="."><plain>The preference for one or the other strategy depends on the prevalence of so-called alarm symptoms, risk factors for a reflux <z:mp ids='MP_0002038'>carcinoma</z:mp> or Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, demographic factors, e. g., age and gender, patient's wish and initial response to empirical therapy with <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> (<z:chebi fb="4" ids="53266">PPI</z:chebi>) </plain></SENT>
<SENT sid="4" pm="."><plain>However, most patients with characteristic reflux symptoms without any alarm symptoms and/or other risk factors can be safely managed with a symptom-based strategy in <z:hpo ids='HP_0011009'>acute</z:hpo> and long-term care </plain></SENT>
</text></document>